2025 Partners
Rules-Based Medicine (an IQVIA business)
Exhibition Partner
Rules-Based Medicine (RBM), an IQVIA business, provides reproducible and quantitative data for +300 immunoassays to support accurate pharmacodynamic and safety assessments from its CLIA-certified biomarker testing laboratory in Austin, TX. We offer multiplexed multi-analyte profiles (MAPs) for the Luminex platform and ultrasensitive Simoa assays, as well as the Olink Target 48 Cytokine panel. To measure immune response, RBM’s TruCulture® tubes deliver an integrated whole-blood collection and leukocyte culture system, preserving physiological cellular interactions and reducing variability for immune monitoring in clinical trials.